Ashu Johri

ORCID: 0000-0002-1579-8583
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • Genetic Neurodegenerative Diseases
  • Adipose Tissue and Metabolism
  • Muscle Physiology and Disorders
  • Alzheimer's disease research and treatments
  • Metabolism and Genetic Disorders
  • Amyotrophic Lateral Sclerosis Research
  • Receptor Mechanisms and Signaling
  • Neurological disorders and treatments
  • Neuroscience and Neuropharmacology Research
  • Nuclear Receptors and Signaling
  • Nerve injury and regeneration
  • COVID-19 Clinical Research Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Long-Term Effects of COVID-19
  • Tryptophan and brain disorders
  • Neurological diseases and metabolism
  • Diet and metabolism studies
  • COVID-19 and Mental Health
  • Nicotinic Acetylcholine Receptors Study
  • Neurogenetic and Muscular Disorders Research

Cornell University
2010-2021

Weill Cornell Medicine
2021

MIND Research Institute
2016-2021

New York Hospital Queens
2011-2014

NewYork–Presbyterian Hospital
2011-2014

Presbyterian Hospital
2011-2013

There is substantial evidence that impairment of peroxisome proliferator-activated receptor (PPAR)-γ-coactivator 1α (PGC-1α) levels and activity play an important role in Huntington's disease (HD) pathogenesis. We tested whether pharmacologic treatment with the pan-PPAR agonist bezafibrate would correct a deficiency PGC-1α exert beneficial effects transgenic mouse model HD. found administration diet restored PGC-1α, PPARs downstream genes to which occur wild-type mice. were significant...

10.1093/hmg/ddr541 article EN Human Molecular Genetics 2011-11-17

Huntington's disease (HD) is an incurable neurological disorder caused by abnormal glutamine repeat expansion in the huntingtin (Htt) protein. In present studies, we investigated role of Transducers Regulated cAMP response element-binding (CREB) protein activity (TORCs) HD, since TORCs play important expression transcriptional co-regulator peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α), whose impaired HD. We found significantly decreased TORC1 levels STHdhQ111 cells...

10.1093/hmg/dds178 article EN Human Molecular Genetics 2012-05-15

Parkinson's disease (PD) is a neurodegenerative in which the etiology of 90 percent patients unknown. Pesticide exposure major risk factor for PD, and paraquat (PQ), pyridaben (PY) maneb (MN) are amongst most widely used pesticides. We studied mRNA expression using transcriptome sequencing (RNA-Seq) ventral midbrain (VMB) striatum (STR) PQ, PY paraquat+maneb (MNPQ) treated mice, followed by pathway analysis. found concordance signaling pathways between three pesticide models both VMB STR as...

10.1371/journal.pone.0036191 article EN cc-by PLoS ONE 2012-05-01

Huntington's disease (HD) is a devastating illness and at present there no modifying therapy or cure for it; management of the limited to few treatment options amelioration symptoms. Recently, we showed that administration bezafibrate, pan-PPAR agonist, increases expression PGC-1α mitochondrial biogenesis, improves phenotype survival in R6/2 transgenic mouse model HD. Since mice represent 'truncated' huntingtin (Htt) HD, tested efficacy bezafibrate 'full-length' Htt model, BACHD mice....

10.1093/hmg/ddw095 article EN Human Molecular Genetics 2016-03-22

<i>Background:</i> Reduced peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α) gene expression has been observed in striatal cell lines, transgenic mouse models of Huntington’s disease (HD), and brain tissue from HD patients. As this protein is a key transcription regulator the many mitochondrial proteins, these observations strongly support role aberrant function pathogenesis HD. The PGC1α undergoes posttranslational modifications that affect its transcriptional...

10.1159/000327910 article EN Neurodegenerative Diseases 2011-01-01
Jana Godau Tobias Lindig Lüdger Schöls Daniela Berg Matthis Synofzik and 95 more Kristian Steen Frederiksen Ellen Garde Arnold Skimminge Charlotte Ryberg Egill Rostrup William F.C. Baaré Hartwig R. Siebner Anne‐Mette Hejl Anne-Mette Leffers Jess G. Fiedorowicz James A. Mills Adam Ruggle Douglas R. Langbehn Jane S. Paulsen V. Orsetti E. Pegoraro V. Cima C. D’Ascenzo A. Palmieri G. Querin Massimo Volpe M. Ermani C. Angelini G. Sorarù Roberta Ghidoni Luisa Benussi Anna Paterlini Valentina Albertini Giuliano Binetti Enzo Emanuele Ashu Johri Anatoly A. Starkov Abhishek Chandra Thomas Hennessey Abhijeet Sharma S. Orobello Ferdinando Squitieri Lichuan Yang Jing Hua Jiang Eun Jin Yang Jaume del Valle Joaquim Duran‐Vilaregut Gemma Manich Mercè Pallàs Antoni Camins Jordi Vilaplana Carme Pelegrı́ Myung Gi Baek Seon Hwy Kim Sang Min Lee Sun‐Mi Choi Julie A. Hawkins David C. Harrison Sharlin Ahmed Robert P. Davis Trevor Chapman I. Howard Marshall B.J. Smith Tania Mead Andrew D. Medhurst Ged M.P. Giblin Adrian M. Hall Maria Gonzalez Jill Richardson Ishrut Hussain Marie‐Pierre Hinault America Farina-Henriquez-Cuendet Pierre Goloubinoff James F. Rooney Päivi Koskenkorva Jelena Hyppönen Marja Äikiä Esa Mervaala Tuula Kiviranta Kai Eriksson Anna‐Elina Lehesjoki Ritva Vanninen Annika Spottke María Stamelou Nicole Cabanel Karla Eggert Günter U. Höglinger Friederike Sixel-Doering Birgit Herting Thomas Klockgether Heinz Reichmann Wolfgang H. Oertel Richard Dodel Yaroslav Winter Reetta Kälviäinen M. Flint Beal Gunhild Waldemar Laura van de Pol Hermann‐Josef Gertz Philip Scheltens

10.1159/000330927 article CA Neurodegenerative Diseases 2011-01-01
Coming Soon ...